Literature DB >> 20167701

Pathologic classification of diabetic nephropathy.

Thijs W Cohen Tervaert1, Antien L Mooyaart, Kerstin Amann, Arthur H Cohen, H Terence Cook, Cinthia B Drachenberg, Franco Ferrario, Agnes B Fogo, Mark Haas, Emile de Heer, Kensuke Joh, Laure H Noël, Jai Radhakrishnan, Surya V Seshan, Ingeborg M Bajema, Jan A Bruijn.   

Abstract

Although pathologic classifications exist for several renal diseases, including IgA nephropathy, focal segmental glomerulosclerosis, and lupus nephritis, a uniform classification for diabetic nephropathy is lacking. Our aim, commissioned by the Research Committee of the Renal Pathology Society, was to develop a consensus classification combining type1 and type 2 diabetic nephropathies. Such a classification should discriminate lesions by various degrees of severity that would be easy to use internationally in clinical practice. We divide diabetic nephropathy into four hierarchical glomerular lesions with a separate evaluation for degrees of interstitial and vascular involvement. Biopsies diagnosed as diabetic nephropathy are classified as follows: Class I, glomerular basement membrane thickening: isolated glomerular basement membrane thickening and only mild, nonspecific changes by light microscopy that do not meet the criteria of classes II through IV. Class II, mesangial expansion, mild (IIa) or severe (IIb): glomeruli classified as mild or severe mesangial expansion but without nodular sclerosis (Kimmelstiel-Wilson lesions) or global glomerulosclerosis in more than 50% of glomeruli. Class III, nodular sclerosis (Kimmelstiel-Wilson lesions): at least one glomerulus with nodular increase in mesangial matrix (Kimmelstiel-Wilson) without changes described in class IV. Class IV, advanced diabetic glomerulosclerosis: more than 50% global glomerulosclerosis with other clinical or pathologic evidence that sclerosis is attributable to diabetic nephropathy. A good interobserver reproducibility for the four classes of DN was shown (intraclass correlation coefficient = 0.84) in a test of this classification.

Entities:  

Mesh:

Year:  2010        PMID: 20167701     DOI: 10.1681/ASN.2010010010

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  435 in total

Review 1.  Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes.

Authors:  Cynthia C Nast; Kevin V Lemley; Jeffrey B Hodgin; Serena Bagnasco; Carmen Avila-Casado; Stephen M Hewitt; Laura Barisoni
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

2.  Role of ultrasonography in the evaluation of correlation between strain and elasticity of common carotid artery in patients with diabetic nephropathy.

Authors:  Chunpeng Zou; Yan Jiao; Xingwang Li; Chao Zheng; Maohua Chen; Chunhong Hu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  Structural Predictors of Renal Function Decline.

Authors:  Susanne B Nicholas
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-20       Impact factor: 8.237

4.  B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Authors:  Elena Gagliardini; Rubina Novelli; Daniela Corna; Carlamaria Zoja; Barbara Ruggiero; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

5.  Deletion of diacylglycerol-responsive TRPC genes attenuates diabetic nephropathy by inhibiting activation of the TGFβ1 signaling pathway.

Authors:  Benju Liu; Xiju He; Shoutian Li; Benke Xu; Lutz Birnbaumer; Yanhong Liao
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

6.  Association between urinary IgG and relative risk for factors affecting proteinuria in type 2 diabetic patients.

Authors:  Sandesh Mohan; Kiran Kalia; Jyoti Mannari
Journal:  Indian J Clin Biochem       Date:  2012-06-24

7.  Segmental Sclerosis and Extracapillary Hypercellularity Predict Diabetic ESRD.

Authors:  Amy K Mottl; Adil Gasim; Fernanda Payan Schober; Yichun Hu; Askia K Dunnon; Susan L Hogan; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2017-11-27       Impact factor: 10.121

Review 8.  Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.

Authors:  Ankur Jindal; Mariana Garcia-Touza; Nidhi Jindal; Adam Whaley-Connell; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-08-01       Impact factor: 4.741

9.  Silent diabetic nephropathy.

Authors:  Katia López-Revuelta; Patricia Peña Galdo; Ramona Stanescu; Leticia Parejo; Carmen Guerrero; Elia Pérez-Fernández
Journal:  World J Nephrol       Date:  2014-02-06

10.  Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.

Authors:  Weier Qi; Hillary A Keenan; Qian Li; Atsushi Ishikado; Aimo Kannt; Thorsten Sadowski; Mark A Yorek; I-Hsien Wu; Samuel Lockhart; Lawrence J Coppey; Anja Pfenninger; Chong Wee Liew; Guifen Qiang; Alison M Burkart; Stephanie Hastings; David Pober; Christopher Cahill; Monika A Niewczas; William J Israelsen; Liane Tinsley; Isaac E Stillman; Peter S Amenta; Edward P Feener; Matthew G Vander Heiden; Robert C Stanton; George L King
Journal:  Nat Med       Date:  2017-04-24       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.